Cyno VEGF predicted identical to human; binds rabbit VEGF with lower affinity (Kd 8.0 vs 1.1 nM)
“Cynomolgus monkey VEGF is predicted to have a protein sequence identical to that of human VEGF [41]. According to the applicant, bevacizumab also binds rabbit VEGF, although with a lower affinity than for human VEGF; the dissociation constant (Kd) is 8.0 nM for rabbit VEGF compared with 1.1 nM for human VEGF.”
No surrogate in toxicology; murine parent A4.6.1 used for pharmacology; clinical antibody tested in monkey and rabbit
“Most submitted pharmacological studies are performed with A4.6.1 but equivalence between bevacizumab and A4.6.1 has been adequately documented with regard to VEGF affinity and anti-proliferative effect.”